Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38684 |
AKR1C3-IN-4
AKR1C3-IN-4 |
NADPH | Metabolism |
AKR1C3-IN-4 是醛酮还原酶 1C3 (AKR1C3) 选择性抑制剂,IC50为 0.56 μM。它在去势抵抗性前列腺癌中有研究的价值。 | |||
T7406 |
AKR1C3-IN-1
3-(3,4-二氢-1H-异喹啉-2-磺酰基)-苯甲酸 |
NADPH | Metabolism |
AKR1C3-IN-1 是高度选择性的 AKR1C3抑制剂(IC50:13 nM)。 | |||
T67846 |
AKR1C3-IN-9
|
NADPH | Metabolism |
AKR1C3-IN-9 是选择性的醛酮还原酶 1C3 (AKR1C3) 抑制剂 (IC50= 8.92 nM)。AKR1C3-IN-9 显著逆转在耐药乳腺癌细胞系对 Doxorubicin (DOX) 耐药性。 | |||
T64193 | AKR1C3-IN-5 | ||
AKR1C3-IN-5 (Compound 6e) 是一种 AKR1C3 的有效抑制剂,来源于 drupanin。AKR1C3 酶在激素依赖性前列腺和乳腺肿瘤中过度表达。AKR1C3-IN-5 能够作用于 MCF-7 细胞 (IC50: 9.6 ± 3 μM; SI: 5.5)。 | |||
T61925 | AKR1C3-IN-7 | ||
AKR1C3-IN-7 (Compound 13) 是有效的、选择性的AKR1C3抑制剂(IC50=0.19 μM)。AKR1C3-IN-7 显示出抗肿瘤活性。 | |||
T61790 | AKR1C3-IN-6 | ||
AKR1C3-IN-6 (Compound 1) is a powerful and specific inhibitor of AKR1C3, with IC50 values of 0.31 μM and 73.23 μM against AKR1C3 and AKR1C2, respectively. It demonstrates significant antitumor activity [1]. | |||
T61926 | AKR1C3-IN-8 | ||
AKR1C3-IN-8 (Compound 5) 是有效的、选择性的AKR1C3抑制剂(IC50=0.069 μM)。AKR1C3-IN-8 显示出抗肿瘤活性。 | |||
T79433 |
AKR1C3-IN-10
|
||
AKR1C3-IN-10 (化合物 5r),作为一种具有选择性的AKR1C3抑制剂 (IC50=51 nM),在前列腺癌异种移植模型中表现出了良好的生物活性。 | |||
T67950 |
S19-1035
|
NADPH | Metabolism |
S19-1035为AKR1C3(aldehyde ketone reductase 1C3)的高效特异性抑制剂,其IC50值为3.04 nM,主要应用于肿瘤研究。 | |||
T27990 |
MDK-0738
AKR1C3-IN-14a,AKR1C3 IN 14a |
||
MDK-0738 is a potent and selective aldo-keto reductase 1C3 inhibitor. | |||
T26196 |
SN34037
SN-34037,SN 34037 |
||
SN34037 is a specific Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) inhibitor. | |||
T61033 | S07-2001 | ||
S07-2001 增强Doxorubicin 抗癌细胞的活性,可作为耐药癌症的化疗增强剂。S07-2001 是有效的醛酮还原酶 1C3 (AKR1C3)的选择性抑制剂,IC50值为 2.08 μM。 | |||
T61003 |
S07-2009
|
||
S07-2009 是一种有效的醛酮还原酶 1C3 (AKR1C3)的选择性抑制剂 (IC 50 = 0.20 μM)。 | |||
T61511 |
S07-2005 (racemic)
|
||
S07-2005 racemic is a chemically potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3), with an IC50 value of 0.13 μM and 0.75 μM for AKR1C3 and AKR1C4, respectively. Due to its inhibitory properties, it exhibits potential as a chemotherapeutic potentiator, specifically in the context of overcoming drug resistance in cancer [1]. | |||
T78199 |
S07-1066
|
Others | Others |
S07-1066为AKR1C3醛酮还原酶抑制剂,增强阿霉素(DOX)细胞毒性作用。该化合物选择性抑制AKR1C3催化的DOX还原反应,逆转AKR1C3高表达细胞的DOX耐药性。 |